A Phase 2, Randomized, Double-blind, Vehicle-controlled, Dose-ranging Study of DRM01B Topical Gel in Subjects With Acne Vulgaris
Phase of Trial: Phase II
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Olumacostat glasaretil (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Dermira
- 17 Mar 2017 According to a Dermira media release, data from this study will be presented at 13th Annual Maui Derm for Dermatologists 2017 meeting.
- 03 Mar 2017 Results published in a Dermira media release.
- 27 Feb 2017 According to a Dermira media release, primary data from the study will be presented during poster sessions at the 75th Annual Meeting of the American Academy of Dermatology (AAD).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History